ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print March 5, 2008, 10.1183/09031936.00137107
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lefebvre, B.
Right arrow Articles by Stanke-Labesque, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lefebvre, B.
Right arrow Articles by Stanke-Labesque, F.
Eur Respir J 2008; 32:113-120
Copyright ©ERS Journals Ltd 2008

Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?

B. Lefebvre1,2,3, J-L. Pépin1,2,4, J-P. Baguet2,5,6, R. Tamisier1,2,4, M. Roustit3, K. Riedweg3, G. Bessard1,2,3, P. Lévy1,2,4 and F. Stanke-Labesque1,2,3

1 INSERM, ERI7, 2 Grenoble University 1, Faculté de Médecine, IFR1, 3 BP217, Pharmacology Laboratory, 4 BP217, EFCR Laboratory, and 5 BP217, Cardiology Unit, A. Michallon Hospital, Centre Hospitalier Universitaire, and 6 INSERM 8777, Grenoble, France.

CORRESPONDENCE: F. Stanke-Labesque, Laboratoire de Pharmacologie, Centre Hospitalier Universitaire, Hôpital A. Michallon, BP 217, 38043 Grenoble Cedex 9, France. Fax: 33 476768938. E-mail: FStanke{at}chu-grenoble.fr

Keywords: Atherosclerosis, leukotriene B4, polymorphonuclear cells, sleep apnoea

Received: October 17, 2007
Accepted February 11, 2008

Severity of oxygen desaturation is predictive of early atherosclerosis in obstructive sleep apnoea (OSA). Leukotriene (LT)B4 is a lipid mediator involved in atherogenesis.

In 40 non-obese OSA patients, free of a cardiovascular history, and 20 healthy volunteers, the following were evaluated: 1) LTB4 production by polymorphonuclear leukocytes (PMNs) stimulated with A23187 [GenBank] ; and 2) the relationships between LTB4 production and both OSA severity and infraclinical atherosclerosis markers. The effect of continuous positive airway pressure (CPAP) on LTB4 production was also studied. An overnight sleep study was followed by first-morning blood sampling. Isolated PMNs were stimulated with A23187 [GenBank] in order to induce LTB4 production, which was measured by liquid chromatography–tandem mass spectrometry. Carotid intima-media thickness (IMT) and luminal diameter were measured in subset groups of 28 OSA patients and 11 controls.

LTB4 production was increased in OSA patients compared with controls. LTB4 levels correlated with the mean and minimal arterial oxygen saturation (Sa,O2). LTB4 production correlated with luminal diameter data in patients with a mean Sa,O2 of ≤94% but not with IMT. Lastly, CPAP significantly reduced LTB4 production by 50%.

Leukotriene B4 production is increased in obstructive sleep apnoea in relation to oxygen desaturation. Leukotriene B4 could promote early vascular remodelling in moderate-to-severe hypoxic obstructive sleep apnoea patients.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the European Respiratory Society.